Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases.

Abstract

Paeonol (2'-hydroxy-4'-methoxyacetophenone) is known to possess anti-inflammatory and anti-proliferative activities. Recently there is evidence that anti-inflammatory agents may be useful in the setting of angiogenesis-related diseases. Thus in the present study the anti-angiogenic activity of paeonol and its mechanism were investigated in vitro and in vivo. Paeonol significantly inhibited proliferation of basic fibroblast growth factor (bFGF)-stimulated human umbilical vein endothelial cells (HUVECs). Paeonol also significantly inhibited migration and tube formation of bFGF-stimulated HUVECs in vitro. In addition, paeonol significantly suppressed neovessel formation on bFGF-treated chick chorioallantoic membrane (CAM) and disrupted bFGF-induced neovascularization in Matrigel plug assay in vivo. Furthermore, paeonol downregluated Akt phosphorylation in bFGF-stimulated HUVECs and reduced expression of matrix metalloproteinases-2 and -9 in HT1080 human fibrosarcoma cells. The Akt inhibitor LY294002 synergistically potentiated paeonol-induced inactivation of Akt and vascular endothelial growth factor in bFGF-treated HUVECs. Taken together, these findings suggest that paeonol can be a potent suppressor of angiogenesis and metastasis partially through inhibition of Akt signaling pathway and matrix metalloproteinase activity.

7 Figures and Tables

05010015020102011201220132014201520162017
Citations per Year

213 Citations

Semantic Scholar estimates that this publication has 213 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Kim2009PaeonolEA, title={Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases.}, author={Seung-Ae Kim and Hyo-Jeong Lee and Kwang Seok Ahn and Hyo-Jung Lee and Eun-Ok Lee and Kyoo-Seok Ahn and Seung-Hoon Choi and Soo-Jin Jung and Ji Young Kim and Namin Baek and Sung-Hoon Kim}, journal={Biological & pharmaceutical bulletin}, year={2009}, volume={32 7}, pages={1142-7} }